Alexion Pharma Polandsp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-03-17
Share capital
5 000,00 PLN
Registered address
ul. Postępu 14, 02-676 Warszawa, Poland
Electronic delivery address
AE:PL-59462-48907-UWHTS-30
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 4.03mMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD 117.28kMedianUSD -1.50kAverageUSD -84.98k
Operating costs
This companyUSD 3.72mMedianUSD 56.25kAverageUSD 2.29m
Assets
This companyUSD 1.28mMedianUSD 116.77kAverageUSD 2.72m
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-08-08. Active
22 1030 1508 0000 0008 2368 4000- 62 1030 1335 0000 0008 2368 4500
- 92 1030 1508 0000 0008 2368 4001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Agata Wiesiołek — Management Board Member
Beata Purzycka — Management Board Member
Manner of representation
Each member of the management board has the right to represent the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Alexion Holding B.v. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Beata Purzycka (52)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Agata Wiesiołek (47) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Proper Medical Writingsp. z o.o. | $464,661.64 | propermedicalwriting.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-09-22 | Address change (Ul. Towarowa 28, 00-839, Warszawa → Ul. Postępu 14, 02-676, Warszawa) | |
| 2022-09-22 | Name change (Lavyport Investments → Alexion Pharma Poland) | |
| 2022-09-22 | PKD change (Removed: 41.10.Z, 41.20.Z, 47.91.Z, 64.20.Z, 64.92.Z, 68.10.Z, 68.20.Z, 68.32.Z, 70.10.Z; Added: 69.20.Z, 70.21.Z, 72.11.Z, 72.19.Z, 73.11.Z, 82.30.Z, 82.99.Z) | |
| 2022-03-17 | Entered in the register |
FAQ
Last updated: 2026-07-04